Re-evaluating the impact and cost-effectiveness of pneumococcal conjugate vaccine introduction in 112 low-income and middle-income countries in children younger than 5 years: a modelling study

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(24)00232-8/fulltext?dgcid=hubspot_update_feature_updatealerts_langlo&utm_campaign=update-langlo&utm_medium=email&_hsenc=p2ANqtz-9wB0PgfJDIdDneRpllXpKgFbhD0Dmbp6fsKDJH7EnisNjzxPBIAjqjoDBRXKorh6xjcZIHvfigYVwMu-MdS9c2UM4f2g&_hsmi=321746938&utm_content=321411332&utm_source=hs_email